Efficacy and Safety of Dexmedetomidine in the Analgesic Prophylaxis , in Patients Undergoing Cardiovascular Surgery
Status:
Recruiting
Trial end date:
2023-10-10
Target enrollment:
Participant gender:
Summary
Acute pain is one of the complications after cardiothoracic surgeries . It can delay
patients´recovery and may increase patients´morbity and mortality. This study intends to
evaluate Dexmedetomidine, a highly selective α- 2 receptor agonist, that is currently applied
safely and efficiently in intraoperative cardiac surgery. It has analgesic, sedative,
anxiolytic and sympatholytic properties, without respiratory- depressant effect. The aim of
this study is to investigate whether the intraoperative use of dexmedetomidine is better than
the standard analgesia used in the intraoperative period to reduce pain and the consequences
of it.